Tekla Life Sciences Fund Manager Performance Evaluation
| XHQLX Fund | USD 15.21 0.11 0.72% |
The entity has a beta of 0.15, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Tekla Life's returns are expected to increase less than the market. However, during the bear market, the loss of holding Tekla Life is expected to be smaller as well.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Tekla Life Sciences has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's essential indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.
...more| Expense Ratio | 1.2200 |
Tekla |
Tekla Life Relative Risk vs. Return Landscape
If you would invest 1,668 in Tekla Life Sciences on October 11, 2024 and sell it today you would lose (136.00) from holding Tekla Life Sciences or give up 8.15% of portfolio value over 90 days. Tekla Life Sciences is currently producing negative expected returns and takes up 1.1855% volatility of returns over 90 trading days. Put another way, 10% of traded mutual funds are less volatile than Tekla, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Tekla Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tekla Life's investment risk. Standard deviation is the most common way to measure market volatility of mutual funds, such as Tekla Life Sciences, and traders can use it to determine the average amount a Tekla Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1116
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | XHQLX |
Estimated Market Risk
| 1.19 actual daily | 10 90% of assets are more volatile |
Expected Return
| -0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Tekla Life is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tekla Life by adding Tekla Life to a well-diversified portfolio.
Tekla Life Fundamentals Growth
Tekla Mutual Fund prices reflect investors' perceptions of the future prospects and financial health of Tekla Life, and Tekla Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tekla Mutual Fund performance.
About Tekla Life Performance
Evaluating Tekla Life's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Tekla Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Tekla Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Tekla Life is entity of United States. It is traded as Fund on NMFQS exchange.Things to note about Tekla Life Sciences performance evaluation
Checking the ongoing alerts about Tekla Life for important developments is a great way to find new opportunities for your next move. Mutual Fund alerts and notifications screener for Tekla Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Tekla Life Sciences generated a negative expected return over the last 90 days |
- Analyzing Tekla Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tekla Life's stock is overvalued or undervalued compared to its peers.
- Examining Tekla Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Tekla Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tekla Life's management team can help you assess the Mutual Fund's leadership.
- Pay attention to analyst opinions and ratings of Tekla Life's mutual fund. These opinions can provide insight into Tekla Life's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Tekla Mutual Fund
Tekla Life financial ratios help investors to determine whether Tekla Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tekla with respect to the benefits of owning Tekla Life security.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |